- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21:58 | ACIP backs block on flu vaccines with thimerosal additive | ||
| 17:58 | UK probes link between GLP-1 drugs and pancreatitis | ||
| 14:59 | First intranasal anaphylaxis drug launches in Germany | ||
| 13:58 | Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen | ||
| 13:58 | Nektar eyes pivotal trials for eczema drug cast off by Lilly | ||
| 11:59 | Could a vaccine adjuvant be protective against dementia? | ||
| 10:58 | Biogen races into phase 3 with Spinraza follow-up | ||
| Mi | Kymera signs $750m cancer deal with Gilead as Sanofi opts in | ||
| Mi | FDA probing deaths with DMD gene therapy Elevidys | ||
| Mi | Alarm as study finds global vaccination coverage stalls | ||
| Mi | Sangamo cues up Fabry gene therapy filing on STAAR data | ||
| Mi | Germany will be first to launch PTC's phenylketonuria drug | ||
| Di | Nuvalent chases after Nuvation in ROS1 lung cancer | ||
| Di | AZ, Daiichi get Datroway nod in lung cancer on second try | ||
| Di | ADA: Vertex closer to weaning type 1 diabetics off insulin | ||
| Di | Novo Nordisk's fling with Hims & Hers ends in a bust-up | ||
| Di | Senator says ACIP next meeting should be postponed | ||
| Mo | NHS records to be harnessed in pancreatic cancer screening | ||
| Mo | EU kicks off review of GSK's linerixibat in PBC | ||
| Mo | Roche's Hemlibra follow-up set for phase 3 in haemophilia A | ||
| Mo | ADA: Lilly makes its case for oral GLP-1 orforglipron | ||
| Mo | ADA: Novo continues effort to rehabilitate CagriSema | ||
| Fr | Madrigal closes on EU approval of first MASH treatment | ||
| Fr | Grail plans FDA filing for cancer blood test after new trial | ||
| Fr | Dupixent is first FDA-approved drug for rare skin disease |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .